ITRI:NASDAQItron, Inc. Analysis
Data as of 2026-06-13 - not real-time
$80.56
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Itron’s stock is trading below its short‑term and mid‑term moving averages, confirming a bearish price momentum while the RSI sits in a neutral zone and the MACD line has just nudged above its signal, hinting at a faint bullish undercurrent.
Fundamentally, the company trades at a low price‑to‑earnings multiple compared with its industry peers, yet a discounted cash‑flow model places intrinsic value beneath the current price, suggesting a mixed valuation picture. Recent expansion of the digital metering partnership with Hunter Water and analyst consensus remaining bullish provide a catalyst that could support a reversal, but high beta, elevated volatility and decreasing volume underscore short‑term uncertainty.
Fundamentally, the company trades at a low price‑to‑earnings multiple compared with its industry peers, yet a discounted cash‑flow model places intrinsic value beneath the current price, suggesting a mixed valuation picture. Recent expansion of the digital metering partnership with Hunter Water and analyst consensus remaining bullish provide a catalyst that could support a reversal, but high beta, elevated volatility and decreasing volume underscore short‑term uncertainty.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical positioning relative to moving averages
- Decreasing trading volume indicating weaker short‑term support
- Mixed valuation signals with DCF suggesting overprice
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic partnership expansion driving potential revenue uplift
- Attractive valuation relative to sector peers
- Strong operating margins and positive cash flow generation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Secular demand for smart‑city and energy‑management solutions
- Recurring revenue streams from outcomes and services segments
- Ability to leverage AI and analytics for higher‑margin offerings
Key Metrics & Analysis
Financial Health
Revenue Growth-3.30%
Profit Margin12.31%
P/E Ratio12.9
ROE18.58%
ROA5.10%
Debt/Equity98.35
P/B Ratio2.2
Op. Cash Flow$419.3M
Free Cash Flow$300.8M
Industry P/E36.8
Technical Analysis
TrendBearish
RSI43.6
Support$77.77
Resistance$86.77
MA 20$81.86
MA 50$85.98
MA 200$100.68
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$69.74
Target Price$126.70
Upside/Downside57.27%
GradeFair
TypeValue
Risk Assessment
Beta1.58
Volatility30.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.